𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response

✍ Scribed by Baishen Chen; Xi Rao; Michael G. House; Kenneth P. Nephew; Kevin J. Cullen; Zhongmin Guo


Book ID
116335673
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
780 KB
Volume
309
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hypermethylation of the somatostatin pro
✍ Zhe Jin; Yuriko Mori; James P. Hamilton; Alexandru Olaru; Fumiaki Sato; Jian Yan πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 235 KB

## Abstract ## BACKGROUND. The promoter of somatostatin (__SST__), a primary inhibitor of gastrin‐stimulated gastric acid secretion, is hypermethylated in 80% of human colon cancers. The aim of the current study was to investigate whether and at what stage promoter hypermethylation of __SST__ is i

CADM1/TSLC1 inactivation by promoter hyp
✍ Kequan Chen; Guanghai Wang; Liang Peng; Side Liu; Xiangsheng Fu; Yu Zhou; Haishe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 410 KB

## Abstract Cell adhesion molecule 1 (CADM1/TSLC1), a putative tumor suppressor involving in cell adhesion, proliferation and apoptosis, is frequently inactivated in several carcinomas due to promoter hypermethylation. But alterations of CADM1/TSLC1 in colorectal carcinogenesis and clinical signifi